Homeopathy for insomnia: A systematic review of research evidence

School of Health and Related Research (ScHARR), University of Sheffield, Regent Court, Sheffield, UK.
Sleep Medicine Reviews (Impact Factor: 8.51). 03/2010; 14(5):329-37. DOI: 10.1016/j.smrv.2009.11.005
Source: PubMed


Insomnia is a common problem which impacts on quality of life. Current management includes psychological and behavioural therapies and/or pharmacological treatments.
To systematically review research evidence for effectiveness of homeopathy in the management of insomnia.
Comprehensive searches of biomedical databases (MEDLINE, EMBASE, CINAHL, Cochrane library, Science Citation Index), homeopathy-specific and complementary medicine-specific databases were conducted.
(A) Homeopathic medicines: four randomised controlled trials (RCTs) compared homeopathic medicines to placebo. All involved small patient numbers and were of low methodological quality. None demonstrated a statistically significant difference in outcomes between groups, although two showed a trend favouring homeopathic medicines and three demonstrated significant improvements from baseline in both groups. A cohort study reported significant improvements from baseline. (B) Treatment by a homeopath: No randomised controlled trials of treatment by a homeopath were identified. One cohort study, three case series and over 2600 case studies were identified.
The limited evidence available does not demonstrate a statistically significant effect of homeopathic medicines for insomnia treatment. Existing RCTs were of poor quality and were likely to have been underpowered. Well-conducted studies of homeopathic medicines and treatment by a homeopath are required to examine the clinical and cost effectiveness of homeopathy for insomnia.

Download full-text


Available from: Clare Relton, Aug 18, 2014
  • Source
    • "It is claimed that the special style of case-taking, a different approach on how to manage conventional therapies, and specific life-style recommendations must both be considered as intrinsic parts of a homeopathic treatment. If so, randomised controlled trials on homeopathic medicines alone might be inappropriate or at least insufficient to research homeopathy as a whole [8, 9]. On this background large-scaled, uncontrolled cohort studies have been conducted which aim to assess health effects by global, patient-centered outcome measures (outcome studies). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background. Cohort studies have reported that patients improve considerably after individualised homeopathic treatment. However, these results may be biased by regression to the mean (RTM). Objective. To evaluate whether the observed changes in previous cohort studies are due to RTM and to estimate RTM adjusted effects. Methods. SF-36 quality-of-life (QoL) data from a German cohort of 2827 chronically diseased adults treated by a homeopath were reanalysed by Mee and Chua's modified t-test. Results. RTM adjusted effects, standardized by the respective standard deviation at baseline, were 0.12 (95% CI: 0.06-0.19, P < 0.001) in the mental and 0.25 (0.22-0.28, P < 0.001) in the physical summary score. Small-to-moderate effects were confirmed for the most individual diagnoses in physical, but not in mental component scores. Under the assumption that the true population mean equals the mean of all actually diseased patients, RTM adjusted effects were confirmed for both scores in most diagnoses. Conclusions. Changes in QoL after treatment by a homeopath are small but cannot be explained by RTM alone. As all analyses made conservative assumptions, true RTM adjusted effects are probably larger than presented.
    Evidence-based Complementary and Alternative Medicine 12/2013; 2013:612890. DOI:10.1155/2013/612890 · 1.88 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Schlafstörungen gehören bei älteren Menschen zu den häufigsten gesundheitlichen Beschwerden. Schlafstörungen wirken sich nicht nur unmittelbar auf die Lebensqualität aus, sondern nehmen einen wechselseitigen Einfluss auf zahlreiche organische Erkrankungen. Die komplexe Ätiologie von Insomnie erfordert eine ausführliche Untersuchung und genaue differenzialdiagnostische Einordnung. Falls ursächliche Faktoren identifiziert werden können, erfolgt eine kausale Behandlung. Nicht-pharmakologische Verfahren und Verhaltensregeln sind Hypnotika vorzuziehen; der Nutzen dieser Maßnahmen ist jedoch nicht gut belegt. Die Wirkung von Hypnotika bei älteren Menschen ist allgemein gering, die meisten Substanzen haben jedoch erhebliche Nebenwirkungen. Zur kurzfristigen Behandlung akuter Schlafstörungen kann jedoch im Einzelfall eine kurzfristige Therapie mit Hypnotika erfolgen. Benzodiazepinrezeptoragonisten oder retardiertes Melatonin sind für diese Indikation in erster Linie geeignet. Eine längerfristige medikamentöse Therapie chronischer Insomnie ist wegen ungewisser Wirkung und zahlreicher unerwünschter Wirkungen der meisten Substanzen in der Regel nicht indiziert. In elderly patients, insomnia is a common symptom. Insomnia exerts immediate negative effects on quality of life, but also shows a strong bidirectional relationship with serious medical problems. The complex etiology of insomnia in elderly persons warrants meticulous diagnostic assessment. In patients with secondary insomnia, therapy of the causative factors is initiated. Non-pharmacological therapies and behavioral advice constitute the mainstay of symptomatic treatment of insomnia. However, in elderly persons, the efficacy of these measures has not been well established. In general, the therapeutic benefit of hypnotic drugs is small. On the other hand, most substances may have considerable negative side effects. For short-term symptomatic treatment of acute insomnia, hypnotic drugs may be employed. For this indication, Benzodiazepine receptor agonists and prolonged-release Melatonin are drugs of first choice. Generally, prolonged treatment of chronic insomnia in elderly patients is not indicated due to the unclear long-term efficacy and negative side effects of the hypnotic drugs currently available. SchlüsselworteInsomnie-Alter-Hypnotika-Benzodiazepine-Melatonin KeywordsInsomnia-Elderly-Hypnotics-Benzodiazepines-Melatonin
    Der Internist 07/2010; 51(7):914-922. DOI:10.1007/s00108-010-2647-9 · 0.31 Impact Factor
  • Source

    Sleep Medicine Reviews 12/2010; 14(6):411. DOI:10.1016/j.smrv.2010.07.004 · 8.51 Impact Factor
Show more